Radioprotection of osteoblasts by a fractionated dose regimen and amifostine Academic Article uri icon

Overview

MeSH Major

  • Amifostine
  • Osteoblasts
  • Radiation-Protective Agents

abstract

  • Both dose fractionation and amifostine have valid roles as radioprotectants for osteoblasts and can act in an additive fashion. Radioprotection of cell growth and viability does not necessarily correlate with preservation of normal cellular function. Combination protocols involving dose fractionation and amifostine may be effective in radioprotection of osteoblasts and normal osseous tissue.

publication date

  • September 18, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/PRS.0b013e318191c5a0

PubMed ID

  • 19182669

Additional Document Info

start page

  • 104S

end page

  • 13S

volume

  • 123

number

  • SUPPL.2S